JP Stock MarketDetailed Quotes

7096 StemCell Institute

Watchlist
  • 1294
  • -18-1.37%
20min DelayNot Open Apr 24 15:30 JST
13.26BMarket Cap42.64P/E (Static)

About StemCell Institute Company

StemCell Institute is engaged in Cell bank business that separates and stores cord blood for regenerative medicine. Cord blood is the baby's blood contained in the umbilical cord and placenta that connects mother and baby. In its umbilical cord blood storage business, upon receiving notification from customers who have contracted, umbilical cord blood collected at obstetric facilities throughout Japan is collected, transported to the company's own cell processing center within 48 hours, and it provides a service to store cells at ultra-low temperature after separating cells from blood.

Company Profile

Symbol7096
Company NameStemCell Institute
Founded1999-08-05
MarketTSE Growth
Fiscal Year Ends03-31
AddressShimbashi, Minato-ku Tamuracho Building
Zip Code105-0001
Phone03-6811-3230

Company Executives

  • Name
  • Position
  • Salary
  • Takafumi Shimizu
  • Representative Director and President
  • --
  • Yumi Okubo
  • Independent Director
  • --
  • Tomoo Yamada
  • Independent Director
  • --
  • Masahide Andou
  • Independent Director
  • --

Market Insights

Warren Buffett Portfolio Warren Buffett Portfolio

Buffett's holdings are the latest portfolio from Berkshire Hathaway. Regarded as a top investor, his trades often signal the market and influence the industry. Buffett's holdings are the latest portfolio from Berkshire Hathaway. Regarded as a top investor, his trades often signal the market and influence the industry.

Unlock Now

Discussing

2025 Buffett shareholders' meeting: What's the new buzz in value investing?
🎙️Discussion 1. In the face of market changes, do you prefer to stick with growth stocks or switch to value stocks? 2. Based on the current Show More